iMeddy

iMeddy

Private
Hong KongHealthcare & Life Scienceshttps://imeddy.com/

Last Round

M&A

Nov 11, 2021

Total Funding Raised

$3.06M

Company Overview

iMeddy is a healthtech company that provides an online medical platform offering medical information, online appointments, video consultations, and a clinic management system.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, EHR & EMR, Patient Engagement, E-commerce

Business Model

B2B2C

Customer Profile

Marketplace Commission, Subscription SaaS, Freemium

AI Layer

Application

Keywords

telemedicine platformclinic management softwarepractice management softwarecross-border drug deliverydigital health platformhealthcare marketplacevideo consultationtelehealth platformcross-border healthcaremedical SaaSonline appointment bookingpatient engagement platformhealth e-commerceEHR & EMRintelligent doctor matching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iMeddy Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

iMeddy Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
M&ANov 11, 2021
Series AOct 27, 2019

Key People

Founding team and executive leadership

Alexander Cheuk

Founder & Chief Executive Officer

Founding Team

iMeddy Investors

Notable investors and investment history

InvestorRounds
500 GlobalSeed
212.VCSeries A
Modus CapitalSeries A
Qatar Science & Technology ParkSeries A, Seed
Kasamar HoldingsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2025

    Monthly visitors increased 50% MoM.

  • Jun 1, 2025

    Monthly visitors increased 40% MoM.

iMeddy Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iMeddy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iMeddy's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range3
Year Founded2018
Last FundingNov 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.